"Since 2006, GENETİKS Global has played a significant role in helping thousands of couples have healthy babies through PGT. Now, we're combining our expertise with Premium PGT-A technology."
This new method utilizes next-generation sequencing (NGS) to analyze both copy number variations (CNV) and single nucleotide polymorphisms (SNP), allowing for the detection of aneuploidy, mosaicism, ploidy analysis, and contamination analysis from a single biopsy sample.
Premium PGT-A offers:
- Ploidy Detection: Identifies all triploid and haploid embryo variants (e.g. 69,XXY; 69,XXX)
- DNA Contamination Detection: Identifies possible contamination from within or outside the laboratory.
- Sibling Embryo Information: Confirms similarities between embryos and ensures laboratory quality control.
- Molecular Fertilization Control: Confirms ploidy status in embryos developed after abnormal fertilization (3PN, 1PN).
Triploidy is a common chromosomal anomaly in first-trimester miscarriages. Classic PGT-A systems using conventional NGS techniques cannot accurately exclude these anomalies. Premium PGT-A can be used not only for triploidy detection but also for evaluating potential contamination risks and tracking sibling embryos.
What does Premium PGT offer compared to classic PGT-A?
Premium PGT-A utilizes two advanced analysis methods (CNV and SNP) simultaneously, providing three additional advantages alongside aneuploidy screening and mosaicism detection.
Don't miss the opportunity to improve your IVF success rates with our Premium PGT-A. Contact us for more information.
(1) Kolarski M, Ahmetovic B, Beres M, Topic R, Nikic V, Kavecan I, Sabic S. Genetic Counseling and Prenatal Diagnosis of Triploidy During the Second Trimester of Pregnancy. Med Arch. 2017 Apr;71(2):144-147. doi: 10.5455/medarh.2017.71.144-147. PMID: 28790549; PMCID: PMC5511524.
